Kirk M. Chan‐Tack
- Infectious Diseases top 5%
- Molecular Biology
- Epidemiology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Physiology top 10%
- Co-authors
- Jonathan W. SimonsDebra BirnkrantKimberly StrubleJ. Bradley NelsonG. Steven BovaScott R. MagnusonTerry J. OpgenorthSean P. Hedican
- Topics
- HIV/AIDS drug development and treatment (7 papers)HIV Research and Treatment (6 papers)Antifungal resistance and susceptibility (5 papers)
- Partner nations
- United StatesIndiaUnited Kingdom
In The Last Decade
Kirk M. Chan‐Tack
47 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 110
- Infectious Diseases 442
- Molecular Biology 417
- Epidemiology 318
- Pulmonary and Respiratory Medicine 251
- Physiology 245
Countries citing papers authored by Kirk M. Chan‐Tack
This map shows the geographic impact of Kirk M. Chan‐Tack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirk M. Chan‐Tack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirk M. Chan‐Tack more than expected).
Fields of papers citing papers by Kirk M. Chan‐Tack
This network shows the impact of papers produced by Kirk M. Chan‐Tack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirk M. Chan‐Tack. The network helps show where Kirk M. Chan‐Tack may publish in the future.
Co-authorship network of co-authors of Kirk M. Chan‐Tack
This figure shows the co-authorship network connecting the top 25 collaborators of Kirk M. Chan‐Tack. A scholar is included among the top collaborators of Kirk M. Chan‐Tack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kirk M. Chan‐Tack. Kirk M. Chan‐Tack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 55 | |
| 2 | 4 | |
| 3 | 28 | |
| 4 | 56 | |
| 5 | 9 | |
| 6 | 2 | |
| 7 | 25 | |
| 8 | 24 | |
| 9 | 2 | |
| 10 | 9 | |
| 11 | 82 | |
| 12 | 9 | |
| 13 | 13 | |
| 14 | 9 | |
| 15 | 41 | |
| 16 | 35 | |
| 17 | 1 | |
| 18 | 47 | |
| 19 | Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetate. | 133 |
| 20 | 3 |
About Kirk M. Chan‐Tack
Kirk M. Chan‐Tack is a scholar working on Virology, Infectious Diseases and Applied Microbiology and Biotechnology, having authored 48 papers that have together received 1.4k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (6 papers) and Antifungal resistance and susceptibility (5 papers). The work is most often cited by research in Virology (181 citations), Infectious Diseases (442 citations) and Microbiology (78 citations). Kirk M. Chan‐Tack has collaborated with scholars based in United States, India and United Kingdom. Frequent co-authors include Jonathan W. Simons, Debra Birnkrant, Kimberly Struble, J. Bradley Nelson, G. Steven Bova, Scott R. Magnuson, Terry J. Opgenorth, Sean P. Hedican, Adam Sherwat and John Farley. Their work appears in journals such as New England Journal of Medicine, The Lancet and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.